Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Wildlife Photographer of the Year People’s Choice finalists announced A prowling puma, a hunting polar bear cub and a ghostly ...

More than 390 million children and adolescents were overweight or obese as of 2022, according to the World Health ...

Without urgent intervention, our study forecasts that more than 80% of adults and close to 60% of adolescents will be ...

The loss of bone mineral density and bone mass is called osteoporosis, a disease that affects an estimated 10 million ...

A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

For years, the mantra that skipping breakfast contributes to obesity has been ingrained in our minds. This idea implies that ...

Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

Obesity also contributes to other risk factors for heart disease, including high cholesterol, high blood pressure, Type 2 ...

Through an analysis of posts on Twitter (now rebranded X) relating to obesity published between April 2019 and December 2022, ...